- Nachrichtendetail
-
24.06.2024 08:09:38 - dpa-AFX: *GSK'S OMJJARA APPROVED IN JAPAN FOR TREATMENT OF MYELOFIBROSIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
GSK PLC LS-,3125 | A3DMB5 | Xetra | 17,930 | 01.07.24 12:18:56 | -0,140 | -0,77% | 17,910 | 17,945 | 17,905 | 18,070 |
